Cancer Immunotherapy: Managing Amino Acids during Forced Aetopy
Author(s) -
Michael John Dochniak
Publication year - 2020
Language(s) - English
DOI - 10.53902/sojpcn.2020.01.000506
Subject(s) - atopy , cancer , medicine , immunotherapy , allergy , cancer immunotherapy , adjuvant , adjuvant therapy , immunology , oncology
Cancer patients of all ages experience great satisfaction with initial positive results from first-line therapy. Adjuvant therapy helps decrease the risk of cancer recurring or metastasizing. This review discusses forced atopy as cancer immunotherapy and explores managing select amino acids to starve metastatic cells during forced atopy (many allergies).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom